PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1383
https://www.valueinhealthjournal.com/article/S1098-3015(12)03096-3/fulltext
Title :
PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03096-3&doi=10.1016/j.jval.2012.08.1383
First page :
A444
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
879